Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii.

Authors:
Zsanett Hajdu Simon Nicolussi Mark Rau László Lorántfy Peter Forgo Judit Hohmann Dezső Csupor Jürg Gertsch

J Nat Prod 2014 Jul 27;77(7):1663-9. Epub 2014 Jun 27.

Department of Pharmacognosy, University of Szeged , H-6720 Szeged, Hungary.

The discovery of the interaction of plant-derived N-alkylamides (NAAs) and the mammalian endocannabinoid system (ECS) and the existence of a plant endogenous N-acylethanolamine signaling system have led to the re-evaluation of this group of compounds. Herein, the isolation of seven NAAs and the assessment of their effects on major protein targets in the ECS network are reported. Four NAAs, octadeca-2E,4E,8E,10Z,14Z-pentaene-12-ynoic acid isobutylamide (1), octadeca-2E,4E,8E,10Z,14Z-pentaene-12-ynoic acid 2'-methylbutylamide (2), hexadeca-2E,4E,9Z-triene-12,14-diynoic acid isobutylamide (3), and hexadeca-2E,4E,9,12-tetraenoic acid 2'-methylbutylamide (4), were identified from Heliopsis helianthoides var. scabra. Compounds 2-4 are new natural products, while 1 was isolated for the first time from this species. The previously described macamides, N-(3-methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide (5), N-benzyl-(9Z,12Z,15Z)-octadecatrienamide (6), and N-benzyl-(9Z,12Z)-octadecadienamide (7), were isolated from Lepidium meyenii (Maca). N-Methylbutylamide 4 and N-benzylamide 7 showed submicromolar and selective binding affinities for the cannabinoid CB1 receptor (Ki values of 0.31 and 0.48 μM, respectively). Notably, compound 7 also exhibited weak fatty acid amide hydrolase (FAAH) inhibition (IC50 = 4 μM) and a potent inhibition of anandamide cellular uptake (IC50 = 0.67 μM) that was stronger than the inhibition obtained with the controls OMDM-2 and UCM707. The pronounced ECS polypharmacology of compound 7 highlights the potential involvement of the arachidonoyl-mimicking 9Z,12Z double-bond system in the linoleoyl group for the overall cannabimimetic action of NAAs. This study provides additional strong evidence of the endocannabinoid substrate mimicking of plant-derived NAAs and uncovers a direct and indirect cannabimimetic action of the Peruvian Maca root.

Download full-text PDF

Source
http://dx.doi.org/10.1021/np500292gDOI Listing
July 2014

Publication Analysis

Top Keywords

cannabimimetic action
8
acid 2'-methylbutylamide
8
octadeca-2e4e8e10z14z-pentaene-12-ynoic acid
8
heliopsis helianthoides
8
helianthoides var
8
acid isobutylamide
8
var scabra
8
lepidium meyenii
8
naas
5
acid
5
μm notably
4
receptor values
4
values 031
4
031 048
4
048 μm
4
maca root
4
notably compound
4
cannabinoid cb1
4
compound exhibited
4
exhibited weak
4

Keyword Occurance

Similar Publications

The Spicy Story of Cannabimimetic Indoles.

Authors:
Allyn C Howlett Brian F Thomas John W Huffman

Molecules 2021 Oct 14;26(20). Epub 2021 Oct 14.

Department of Chemistry, Clemson University, Clemson, SC 29634, USA.

The Sterling Research Group identified pravadoline as an aminoalkylindole (AAI) non-steroidal anti-inflammatory pain reliever. As drug design progressed, the ability of AAI analogs to block prostaglandin synthesis diminished, and antinociceptive activity was found to result from action at the CB cannabinoid receptor, a G-protein-coupled receptor (GPCR) abundant in the brain. Several laboratories applied computational chemistry methods to ultimately conclude that AAI and cannabinoid ligands could overlap within a common binding pocket but that WIN55212-2 primarily utilized steric interactions via aromatic stacking, whereas cannabinoid ligands required some electrostatic interactions, particularly involving the CB helix-3 lysine. Read More

View Article and Full-Text PDF
October 2021
Similar Publications

The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.

Authors:
Julien C Dodu Rebecca K Moncayo M Imad Damaj Joel E Schlosburg Hamid I Akbarali Lesley D O'Brien Debra A Kendall Zhixing Wu Dai Lu Aron H Lichtman

J Pharmacol Exp Ther 2022 01 8;380(1):1-14. Epub 2021 Oct 8.

Department of Pharmacology & Toxicology (J.C.D., R.K.M., M.I.D., J.E.S., H.I.A., L.D.O., A.H.L.), and Department of Medicinal Chemistry (A.H.L.), Virginia Commonwealth University, Richmond, Virginia; Department of Pharmaceutical Sciences, University of Connecticut, Mansfield, Connecticut (D.A.K.); and Department of Pharmaceutical Sciences, Texas A&M, College Station, Texas (Z.W., D.L.).

Opioid use disorder reflects a major public health crisis of morbidity and mortality in which opioid withdrawal often contributes to continued use. However, current medications that treat opioid withdrawal symptoms are limited by their abuse liability or lack of efficacy. Although cannabinoid 1 (CB) receptor agonists, including Δ-tetrahydrocannabinol, ameliorate opioid withdrawal in both clinical and preclinical studies of opioid dependence, this strategy elicits cannabimimetic side effects as well as tolerance and dependence after repeated administration. Read More

View Article and Full-Text PDF
January 2022
Similar Publications

Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity.

Authors:
Justin E LaVigne Ryan Hecksel Attila Keresztes John M Streicher

Sci Rep 2021 04 15;11(1):8232. Epub 2021 Apr 15.

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.

Limited evidence has suggested that terpenes found in Cannabis sativa are analgesic, and could produce an "entourage effect" whereby they modulate cannabinoids to result in improved outcomes. However this hypothesis is controversial, with limited evidence. We thus investigated Cannabis sativa terpenes alone and with the cannabinoid agonist WIN55,212 using in vitro and in vivo approaches. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.

Authors:
Jakub Mlost Marta Bryk Katarzyna Starowicz

Int J Mol Sci 2020 Nov 23;21(22). Epub 2020 Nov 23.

Department of Neurochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.

Cannabis has a long history of medical use. Although there are many cannabinoids present in cannabis, Δ9tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two components found in the highest concentrations. CBD itself does not produce typical behavioral cannabimimetic effects and was thought not to be responsible for psychotropic effects of cannabis. Read More

View Article and Full-Text PDF
November 2020
Similar Publications

Cannabinoidomics - An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome.

Authors:
Paula Berman Liron Sulimani Anat Gelfand Keren Amsalem Gil M Lewitus David Meiri

Talanta 2020 Nov 10;219:121336. Epub 2020 Jul 10.

The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel. Electronic address:

Increasing evidence for the therapeutic potential of Cannabis in numerous pathological and physiological conditions has led to a surge of studies investigating the active compounds in different chemovars and their mechanisms of action, as well as their efficacy and safety. The biological effects of Cannabis have been attributed to phytocannabinoid modulation of the endocannabinoid system. In-vitro and in-vivo studies have shown that pure phytocannabinoids can alter the levels of endocannabinoids and other cannabimimetic lipids. Read More

View Article and Full-Text PDF
November 2020
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap